Metabolic & Body Comp
Clinical
Research chemical

Cagrilintide

Also known as AM833 · long-acting amylin analog

New

Reconstitution & dosing guide

5 mg · 10 mg vial sizes — research phases, recon steps, and a live unit calculator.

Open guide

Available sizes & price

Catalog only

10mg x 10 vials

Cagrilintide (CGL10) · Not in current stock

$75 / vial

Add

5mg x 10 vials

Cagrilintide (CGL5) · Not in current stock

$45 / vial

Add

Prices per vial · Research use only · Not medical advice.

Long-acting amylin analog studied alone and with semaglutide (CagriSema) for obesity.

How to picture it

Amylin is a partner hormone secreted with insulin; it signals satiety and slows gastric emptying through amylin receptors. Cagrilintide is a long-acting amylin analog — picture the pancreas's second "we're full" pager, strengthened and extended so the fullness signal doesn't vanish in minutes. Highly complementary to GLP-1 pathways when research wants dual satiety architecture.

Research focus & benefits

  • Long-acting amylin satiety research
  • Gastric emptying and meal-size pathway interest
  • Strong pairing concept with GLP-1 agonists

Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.

Overview

Cagrilintide mimics amylin, a pancreatic hormone that promotes satiety and slows gastric emptying. Combined with semaglutide in CagriSema trials, it is a major pipeline obesity therapy. Not broadly available as an approved solo consumer drug in most markets.

Mechanism

Amylin receptor agonism → satiety, reduced food intake, delayed gastric emptying.

Research uses

  • Obesity combination therapy
  • Satiety research

Research dosing notes

Trial protocols only; not a DIY stack ingredient.

Open full reconstitution & dosing guide →

Half-life / kinetics

Long-acting (weekly-style regimens in trials)

Common research routes

Subcutaneous injection

Reported considerations

  • Nausea
  • GI effects
  • Amylin-class tolerability issues

Contraindications / cautions

  • Investigational use constraints
  • Pregnancy

Common research stacks

  • Semaglutide (CagriSema research)

Legal / access note

Investigational; not a standard approved monotherapy for consumer use.